Paper34866972
Hesperidin and its aglycone hesperetin in breast cancer therapy: A review of recent developments and future prospects.
Yap KM and 9 others. Saudi J Biol Sci, 2021. Cited by 56 papers, by iCite.
Cite this record
ConductScience Library. Hesperidin and its aglycone hesperetin in breast cancer therapy: A review of recent developments and future prospects. Papers, record 34866972. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/34866972
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Hesperidin and its aglycone hesperetin in breast cancer therapy: A review of recent developments and future prospects.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References134
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 28149048 | Molecular mechanisms and mode of tamoxifen resistance in breast cancer. | Bioinformation | 2016 | https://conductscience.org/library/papers/28149048 | PubMed |
| 2 | 24829923 | Downregulation of Bcl-2 expression by miR-34a mediates palmitate-induced Min6 cells apoptosis. | J Diabetes Res | 2014 | https://conductscience.org/library/papers/24829923 | PubMed |
| 3 | 25394264 | Antioxidant and anti-inflammatory properties of the citrus flavonoids hesperidin and hesperetin: an updated review of their molecular mechanisms and experimental models. | Phytother Res | 2015 | https://conductscience.org/library/papers/25394264 | PubMed |
| 4 | 32277430 | A review of the hepatoprotective effects of hesperidin, a flavanon glycoside in citrus fruits, against natural and chemical toxicities. | Daru | 2020 | https://conductscience.org/library/papers/32277430 | PubMed |
| 5 | 26679767 | Natural Products as a Vital Source for the Discovery of Cancer Chemotherapeutic and Chemopreventive Agents. | Med Princ Pract | 2016 | https://conductscience.org/library/papers/26679767 | PubMed |
| 6 | 25204891 | Hesperetin Induces Apoptosis in Breast Carcinoma by Triggering Accumulation of ROS and Activation of ASK1/JNK Pathway. | J Cell Physiol | 2015 | https://conductscience.org/library/papers/25204891 | PubMed |
| 7 | 33277608 | Engineering precision nanoparticles for drug delivery. | Nat Rev Drug Discov | 2021 | https://conductscience.org/library/papers/33277608 | PubMed |
| 8 | 25857269 | Doxorubicin resistance in breast cancer is driven by light at night-induced disruption of the circadian melatonin signal. | J Pineal Res | 2015 | https://conductscience.org/library/papers/25857269 | PubMed |
| 9 | 23704778 | Proteomic signatures of acquired letrozole resistance in breast cancer: suppressed estrogen signaling and increased cell motility and invasiveness. | Mol Cell Proteomics | 2013 | https://conductscience.org/library/papers/23704778 | PubMed |
| 10 | 27449398 | Hesperetin and Naringenin sensitize HER2 positive cancer cells to death by serving as HER2 Tyrosine Kinase inhibitors. | Life Sci | 2016 | https://conductscience.org/library/papers/27449398 | PubMed |
| 11 | 32211328 | Editorial: The Role of Breast Cancer Stem Cells in Clinical Outcomes. | Front Oncol | 2020 | https://conductscience.org/library/papers/32211328 | PubMed |
| 12 | 29095640 | Recent advances in metal nanoparticles in cancer therapy. | J Drug Target | 2018 | https://conductscience.org/library/papers/29095640 | PubMed |
| 13 | 27998284 | The glucose transporter GLUT1 is required for ErbB2-induced mammary tumorigenesis. | Breast Cancer Res | 2016 | https://conductscience.org/library/papers/27998284 | PubMed |
| 14 | 25543329 | Breast Cancer: Epidemiology and Etiology. | Cell Biochem Biophys | 2015 | https://conductscience.org/library/papers/25543329 | PubMed |
| 15 | 28364779 | The effects of Nobiletin, Hesperetin, and Letrozole in a combination on the activity and expression of aromatase in breast cancer cells. | Cell Mol Biol (Noisy-le-grand) | 2017 | https://conductscience.org/library/papers/28364779 | PubMed |
| 16 | 30597838 | Flavonoids in Cancer and Apoptosis. | Cancers (Basel) | 2018 | https://conductscience.org/library/papers/30597838 | PubMed |
| 17 | 22558136 | Strategic cell-cycle regulatory features that provide mammalian cells with tunable G1 length and reversible G1 arrest. | PLoS One | 2012 | https://conductscience.org/library/papers/22558136 | PubMed |
| 18 | 26005359 | Clinical utilities of aromatase inhibitors in breast cancer. | Int J Womens Health | 2015 | https://conductscience.org/library/papers/26005359 | PubMed |
| 19 | 24169409 | Antimicrobial effect of 7-O-butylnaringenin, a novel flavonoid, and various natural flavonoids against Helicobacter pylori strains. | Int J Environ Res Public Health | 2013 | https://conductscience.org/library/papers/24169409 | PubMed |
| 20 | 18515333 | Metabolism and transport of the citrus flavonoid hesperetin in Caco-2 cell monolayers. | Drug Metab Dispos | 2008 | https://conductscience.org/library/papers/18515333 | PubMed |
Cited by33
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 56 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42946846 | Hesperetin-loaded transethosomes for management of skin cancer: formulation and optimization by Box-Behnken design and in vitro, ex vivo, and dermatokinetic studies. | Naunyn Schmiedebergs Arch Pharmacol | 2026 | https://conductscience.org/library/papers/42946846 | PubMed |
| 42640444 | Anti-inflammatory phytochemicals from medicinal herbs based on senoinflammation schema for healthy aging. | Arch Pharm Res | 2026 | https://conductscience.org/library/papers/42640444 | PubMed |
| 42270667 | Effects of monoglucosyl hesperidin on human lymphatic circulatory function: A randomized placebo-controlled, double-blind, crossover trial. | Sci Rep | 2026 | https://conductscience.org/library/papers/42270667 | PubMed |
| 42076034 | Chemical Composition of Eriodictyon californicum (California Yerba Santa) Cultivated in Ontario, Oregon, USA. | Molecules | 2026 | https://conductscience.org/library/papers/42076034 | PubMed |
| 41082699 | Hesperidin and Hesperetin from Orange Peel Water Extract Protect against NaIO3-Induced Oxidative Damage in Retinal Pigment Epithelial Cells by Modulating PI3K/Akt/HIF-1α/BNIP3 Signaling. | J Agric Food Chem | 2025 | https://conductscience.org/library/papers/41082699 | PubMed |
| 40889009 | Orange peel extract and hesperidin attenuate myeloperoxidase activity and oxidative stress in vitro, with anti-inflammatory effects in vivo: a natural approach to gingival protection. | Inflammopharmacology | 2025 | https://conductscience.org/library/papers/40889009 | PubMed |
| 40872219 | Enhanced Recovery of Bioactive Compounds from Cagaita and Mamacadela Fruits Using Natural Deep Eutectic Solvents (NADES) and Ethanol: A Comparative Study. | Plants (Basel) | 2025 | https://conductscience.org/library/papers/40872219 | PubMed |
| 40751800 | Hesperetin increases membrane progesterone receptor expression in human myeloid leukemia cells and reduces ROS. | Med Oncol | 2025 | https://conductscience.org/library/papers/40751800 | PubMed |
| 40533769 | Aurora kinases signaling in cancer: from molecular perception to targeted therapies. | Mol Cancer | 2025 | https://conductscience.org/library/papers/40533769 | PubMed |
| 39861675 | Application of the Box-Behnken Design in the Development of Amorphous PVP K30-Phosphatidylcholine Dispersions for the Co-Delivery of Curcumin and Hesperetin Prepared by Hot-Melt Extrusion. | Pharmaceutics | 2024 | https://conductscience.org/library/papers/39861675 | PubMed |
| 39753522 | Upshot of Some Bioactive Compounds on Angiogenesis in Retinal Pigment Epithelial Cells. | J Cell Mol Med | 2025 | https://conductscience.org/library/papers/39753522 | PubMed |
| 39638981 | Targeting Nudix Hydrolase 5 with Bioactive Flavonoids: Molecular Dynamics and Docking Studies for Breast Cancer Therapy. | Cell Biochem Biophys | 2025 | https://conductscience.org/library/papers/39638981 | PubMed |
| 39614277 | Enhancing radiotherapy in triple-negative breast cancer with hesperetin-induced ferroptosis via AURKA targeting nanocomposites. | J Nanobiotechnology | 2024 | https://conductscience.org/library/papers/39614277 | PubMed |
| 39534464 | Blood circulation effect of fermented citrus bioconversion product (FCBP) in EA.hy926 endothelial cells and high-fat diet-fed mouse model. | Food Nutr Res | 2024 | https://conductscience.org/library/papers/39534464 | PubMed |
| 39220884 | Advancements in precision nanomedicine design targeting the anoikis-platelet interface of circulating tumor cells. | Acta Pharm Sin B | 2024 | https://conductscience.org/library/papers/39220884 | PubMed |
| 38591206 | Exploring the Therapeutic Potential of Flavonoids in the Management of Cancer. | Curr Pharm Biotechnol | 2025 | https://conductscience.org/library/papers/38591206 | PubMed |
| 38525971 | Therapeutic Implications of Dietary Polyphenols-Loaded Nanoemulsions in Cancer Therapy. | ACS Appl Bio Mater | 2024 | https://conductscience.org/library/papers/38525971 | PubMed |
| 38327657 | Phyto-therapeutics as anti-cancer agents in breast cancer: Pathway targeting and mechanistic elucidation. | Saudi J Biol Sci | 2024 | https://conductscience.org/library/papers/38327657 | PubMed |
| 38201037 | Mass Spectrometry Rearrangement Ions and Metabolic Pathway-Based Discovery of Indole Derivatives during the Aging Process in Citrus reticulata 'Chachi'. | Foods | 2023 | https://conductscience.org/library/papers/38201037 | PubMed |
| 38107455 | Study of hesperetin effect on modulating transcription levels of MLH1 and MSH2 genes in SKBR3 breast cancer cell line. | J Adv Pharm Technol Res | 2023 | https://conductscience.org/library/papers/38107455 | PubMed |
Genes75
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/34866972
GET https://conductscience.org/api/papers/v1/34866972/references?page=2